Aktie A204840 GL PHARM TECH CORP.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen GL Pharm Tech Corp.

Aktien

A204840

KR7204840003

A204840

Schlusskurs Korea S.E.
Andere Börsenplätze
 00:00:00 04.06.2024 		% 5 Tage % 1. Jan.
1.184 KRW -1,58 % Intraday Chart für GL Pharm Tech Corp. +1,46 % +4,23 %
03.05. Ein nicht genannter Käufer hat 3,23% der Anteile an GL Pharm Tech Corp. (KOSDAQ:A204840) von Ideal Private Equity Fund für 3,97 Mrd. KRW erworben. CI
06.03. W Science Co., Ltd. hat die Übernahme von 14,75% der Anteile an GL Pharm Tech Corp. (KOSDAQ:A204840) von Ideal Private Equity Fund abgeschlossen CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
An undisclosed buyer acquired 3.23% stake in GL Pharm Tech Corp. from Ideal Private Equity Fund for KRW 3.97 billion.
W Science Co., Ltd. completed the acquisition of 14.75% stake in GL Pharm Tech Corp. from Ideal Private Equity Fund
GL Pharm Tech Corp. announced that it has received KRW 9.199999458 billion in funding from W Science Co., Ltd.
GL Pharm Tech to Raise 9.2 Billion Won via Share Issuance; Shares Decline 7%
GL Pharm Tech Corp. announced that it expects to receive KRW 9.199999458 billion in funding from W Science Co., Ltd.
W Science Co., Ltd. agreed to acquire a 14.7% stake in GL Pharm Tech Corp.
GL Pharm Tech Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023
GL Pharm Tech Corp. Auditor Raises 'Going Concern' Doubt
GL Pharm Tech Corp. Auditor Raises 'Going Concern' Doubt
GL Pharm Tech Corp. announced that it expects to receive KRW 8.999999634 billion in funding from Ideal Private Equity Fund
GL Pharm Tech Corp. announced that it has received KRW 1.000000232 billion in funding from Kyperion Co., Ltd.
GL Pharm Tech Corp. announced that it expects to receive KRW 1.000000232 billion in funding from Kyperion Co., Ltd.
GL Pharm Tech Corp. announced that it has received KRW 1.000000534 billion in funding from Kuhnil Pharmaceutical Co., Ltd.
GL Pharm Tech Corp. announced that it expects to receive KRW 1.000000534 billion in funding from Kuhnil Pharmaceutical Co., Ltd.
GL Pharm Tech Corp. announced that it has received KRW 3.1 billion in funding from Unione Communications Co., Ltd.
GL Pharm Tech Corp. announced that it expects to receive KRW 3.1 billion in funding from Unione Communications Co., Ltd. and other investors
Crown Pharm Co., Ltd. announced that it has received KRW 1.00001 billion in funding from GL Pharm Tech Corp.
Crown Pharm Co., Ltd. announced that it has received KRW 3.00003 billion in funding from GL Pharm Tech Corp.
GL Pharm Tech Corp. announced that it has received KRW 7 billion in funding from Shinhan Investment Corp., Investment Arm, Samsung Securities Co. Ltd., Investment Arm, E&INVESTMENT INC. and other investors
GL Pharm Tech Corp. announced that it expects to receive KRW 7 billion in funding from Shinhan Investment Corp., Investment Arm, Samsung Securities Co. Ltd., Investment Arm, E&INVESTMENT INC., and other investors
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A204840 Aktie
  4. Nachrichten GL Pharm Tech Corp.
  5. Andere Sprachen
-40 % Zeitlich begrenztes Angebot: Unsere Abonnements führen Sie zu den besten Investitionen von morgen.
PROFITIEREN SIE JETZT